Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin.

Asano, Airi; Sowa-Osako, Junko; Umekoji-Hayashi, Ayano; Teramae, Ayako; Fukai, Kazuyoshi; Tsuruta, Daisuke

Asano, Airi; Sowa-Osako, Junko; Umekoji-Hayashi, Ayano; Teramae, Ayako; Fukai, Kazuyoshi; Tsuruta, Daisuke.

Afiliação

Asano A; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Sowa-Osako J; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Umekoji-Hayashi A; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Teramae A; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Fukai K; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tsuruta D; Department of Dermatology, Osaka City General Hospital, Osaka, Japan.

Contact Dermatitis ; 85(5): 590-591, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34129244

Assuntos

Antibacterianos/efeitos adversos; Claritromicina/efeitos adversos; Toxidermias/etiologia; Adulto; Diagnóstico Diferencial; Feminino; Humanos; Testes do Emplastro

Palavras-chave

case report; clarithromycin; nonpigmenting fixed drug eruption; oral provocation test; patch test; pigmenting fixed drug eruption

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Claritromicina / Toxidermias / Antibacterianos Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google